Development of a Three‐Dimensional Bioengineering Technology to Generate Lung Tissue for Personalized Disease Modeling
Open Access
- 7 June 2018
- journal article
- unit
- Published by Wiley in Current Protocols in Stem Cell Biology
- Vol. 46 (1) , e56
Abstract
This unit describes a protocol for generation of lung organoids. A lung organoid is a 3D cell/hydrogel composite that resembles the morphology and cellular composition of the human distal lung. These tissue‐engineered constructs provide an in vitro model of human lung and are best suited for disease modeling applications. The organoid generation methodology is flexible, allowing for easy scalability in the number of organoids produced and in the ability to accommodate a wide range of cell types. © 2018 by John Wiley & Sons, Inc.Keywords
Funding Information
- National Science Foundation
This publication has 9 references indexed in Scilit:
- Engineering De Novo Assembly of Fetal Pulmonary OrganoidsTissue Engineering Part A, 2014
- The burden of idiopathic pulmonary fibrosis: An unmet public health needRespiratory Medicine, 2014
- Fibroblasts Derived from Human Pluripotent Stem Cells Activate Angiogenic Responses In Vitro and In VivoPLOS ONE, 2013
- Human stem cells and drug screening: opportunities and challengesNature Reviews Drug Discovery, 2010
- Three-Dimensional Cell Culture Matrices: State of the ArtTissue Engineering Part B: Reviews, 2008
- Mussel-Inspired Surface Chemistry for Multifunctional CoatingsScience, 2007
- Gene expression perturbation in vitro—A growing case for three-dimensional (3D) culture systemsSeminars in Cancer Biology, 2005
- Investigation of swelling/degradation behaviour of alginate beads crosslinked with Ca2+ and Ba2+ ionsReactive and Functional Polymers, 2004
- Electrostatic droplet generation: Mechanism of polymer droplet formationAIChE Journal, 1994